The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial

Pediatrics

Volumn 102, Issue 4 I, 1998, Pages 909-912

  Cherry, James D ^a,c   Heininger, Ulrich ^b   Stehr, Klemens ^b   Christenson, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acellular pertussis vaccine; Investigation compliance; Observer bias; Vaccine efficacy; Whole cell pertussis vaccine

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BORDETELLA PERTUSSIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; OBSERVER VARIATION; PATIENT CODING; PATIENT COMPLIANCE; PERTUSSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

CLINICAL TRIALS; DOUBLE-BLIND METHOD; HUMANS; INFANT; LONGITUDINAL STUDIES; OBSERVER VARIATION; OUTCOME ASSESSMENT (HEALTH CARE); PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 0031664127     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.102.4.909     Document Type: Article

References (19)

1. Stehr K, Cherry JD, Heininger U, et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine or DT vaccine. Pediatrics. 1998;101:1-11
2. Schmitt HJ, Wirsing von König CH, Neiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA. 1996;275:37-41
3. Simondon F, Preziosi M, Yam A, et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine. 1997;15:1606-1612
4. Trollfors B, Taranger J, Lagergård T, et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med. 1995;333:1045-1050
5. Gustafsson L, Hallander H, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996;334:349-355
6. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med. 1996;334:341-348
7. Liese JG, Meschievitz CK, Harzer E, et al. Efficacy of a two-component acellular pertussis vaccine in infants. Pediatr Infect Dis J. 1997;16: 1038-1044
8. Heininger U, Cherry JD, Stehr K, et al. Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pediatrics. 1998;102:546-553
9. Heininger U, Cherry JD, Eckhardt T, Lorenz C, Christenson P, Stehr K. Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr Infect Dis J. 1993;12:504-509
10. Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics. 1997;100(6). URL: http://www.pediatrics.org/cgi/ content/full/100/6/e10
11. WHO meeting on case definition of pertussis. Geneva, Switzerland: WHO; January 10-11, 1991; Document MIN/EPI/PERT/91.1 1991:4-5
12. Storsaeter J, Hallander H, Farrinton CP, Olin P, Möllby R, Miller E. Secondary analyses of the efficacy of two acellular vaccines evaluated in a Swedish phase III trial. Vaccine. 1990;8:457-461
13. Cherry J. The common cold. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia, PA: WB Saunders; 1998:128-133
14. Wald E, Guerra N, Byers C. Upper respiratory infections in young children: duration of and frequency of complications. Pediatrics. 1991; 87:129-133
15. Fine PEM. Implications of different study designs for the evaluation of acellular pertussis vaccines. Dev Biol Stand. 1997;89:866-883
16. Swedish Institute for Infectious Disease Control. Efficacy trial of acellular pertussis vaccines. Technical Report Trial 1. Stockholm, Sweden: Swedish Institute for Infectious Disease Control; 1995
17. Cherry JD. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr Infect Dis J. 1997;16:S90-S96
18. Taranger J, Trollfors B, The Göteborg Pertussis Vaccine Study. On observer errors in pertussis vaccine studies. Pediatr Infect Dis J. 1997;16: 914
19. Cherry JD. On observer errors in pertussis vaccine studies. Pediatr Infect Dis J. 1997;16:914-915. Reply